2020
DOI: 10.1016/j.radi.2019.11.057
|View full text |Cite
|
Sign up to set email alerts
|

Evaluating the use of exactrac software for CBCT analysis during the development of an oligometastatic spinal SABR service

Abstract: Introduction: Patients with oligometastases are candidates for targeted therapy (1) , such as SABR. This allows delivery of biologically more potent dose, which may provide better local control and is advantageous for these patients (2). A disadvantage of SABR however is the lengthy time to deliver each high dose treatment (3). Clinicians currently supervise treatment delivery but this is insufficient use of a clinician's time (4). With SABR treatments likely to increase over coming years implementation of a R… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
references
References 0 publications
0
0
0
Order By: Relevance